Successful Completion of First Patient Implantation of MINI WELL(R)and MINI WELL TORIC(R) Extended Depth-of-Focus IOLs in China Announced
PR94152
Successful Completion of First Patient Implantation of MINI WELL(R)and MINI WELL TORIC(R) Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI
CATANIA, Italy, Jan. 20, 2022 /PRNewswire=KYODO JBN/ --
SIFI, a leading international ophthalmic company headquartered in Italy, is
pleased to divulge the successful completion of the first patient implantation
of MINI WELL(R) and MINI WELL TORIC(R) IOLs in China, announced via Affamed
Technologies, Joint Venture between AffaMed Therapeutics and SIFI.
MINI WELL(R)and MINI WELL TORIC(R) IOLs were successfully implanted following
phacoemulsification cataract surgical procedures performed at Hainan (Boao)
International Eye and Vision Hospital by Professor Wei CHEN, President of
Hainan (Boao) International Eye and Vision Hospital and Vice President of
Wenzhou Medical University's Eye and Vision Hospital.
Chinese patients are the newest to date to benefit from SIFI's premium
innovative intraocular lenses technology, an important option effectively and
frequently employed in Europe and in numerous Asia Pacific geographies,
including: New Zealand, Japan, South Korea, Hong Kong, Singapore, Philippines,
Vietnam, Malaysia, Indonesia, India and Pakistan.
About MINI WELL(R) and MINI WELL TORIC(R) EDOF IOLs
Developed by SIFI, MINI WELL(R) and MINI WELL TORIC(R) Extended Depth-of-Focus
(EDOF) IOLs are innovative IOL implants, offering a great alternative to
refraction, diffraction and segment-types mono/bi/tri-focal IOLs, as well as to
diffraction-type EDOF IOLs.
Mini WELL and Mini WELL Toric are aspheric, single-piece EDOF IOLs specific for
the surgical technique of mini-incision and designed for correcting astigmatism
and presbyopia. They are made of a hydrophilic-hydrophobic copolymer which has
a high refractive index and excellent mechanical properties.
Mini WELL and Mini WELL Toric are based on a unique patented refractive design
which creates one continuous, extended focus for sharp vision from far to near
and a reduced dependence from spectacles.
ABOUT SIFI
SIFI is a leading international ophthalmic company, headquartered in Italy,
focusing on eye care since 1935. SIFI develops, manufactures and markets
innovative therapeutic solutions for patients with ophthalmic conditions. SIFI
is fully committed through its R&D to improve the quality of life of patients,
exporting treatments to more than 20 countries worldwide with a direct presence
in Italy, Spain, France, Romania, Mexico and Turkey.
ABOUT AFFAMED TECHNOLOGIES
Established in 2021, AffaMed Technologies is the joint venture between AffaMed
Therapeutics and SIFI S.p.A. ("SIFI"), a leading international ophthalmology
company headquartered in Italy, to develop, manufacture and commercialize
premium intraocular lenses ("IOLs") in the Greater China market.
Logo - https://mma.prnewswire.com/media/1337809/SIFI_Logo.jpg
Source: SIFI SpA
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。